New Jersey Senate Bill 301 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Democrat 8-0)
Status: Introduced on January 11 2022 - 25% progression, died in committee
Action: 2022-01-11 - Introduced in the Senate, Referred to Senate Commerce Committee
Pending: Senate Commerce Committee
Text: Latest bill text (Introduced) [HTML]

Provides that purchase of insulin is not subject to deductible and requires health insurers to limit copayments and coinsurance for insulin.

Provides that purchase of insulin is not subject to deductible and requires health insurers to limit copayments and coinsurance for insulin.

Sen. Joseph Vitale [D]	Sen. Nellie Pou [D]	Sen. Shirley Turner [D]	Sen. Teresa Ruiz [D]
Sen. Fred Madden [D]	Sen. Joseph Lagana [D]	Sen. Vin Gopal [D]	Sen. Andrew Zwicker [D]

Date	Chamber	Action
2022-01-11	Senate	Introduced in the Senate, Referred to Senate Commerce Committee

S301 (Carry Over) 2022-01-11 - Introduced in the Senate, Referred to Senate Commerce Committee
S526 (Carry Over) 2021-03-17 - Recommitted to Assembly Appropriations Committee
A954 (Carry Over) 2021-06-16 - Reported out of Assembly Comm. with Amendments, 2nd Reading
A653 (Carry Over) 2020-02-13 - Combined with A954/1669 (ACS)
A1669 (Carry Over) 2020-02-13 - Combined with A954/653 (ACS)
A553 (Same As) 2022-01-11 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
S3588 (Carry Over) 2021-03-25 - Introduced in the Senate, Referred to Senate Commerce Committee
A5268 (Carry Over) 2021-01-25 - Introduced, Referred to Assembly Human Services Committee

Type	Source
Summary	https://www.njleg.state.nj.us/bill-search/2022/S301
Text	https://pub.njleg.gov/Bills/2022/S0500/301_I1.HTM